Biohazard waste bags are specialized containment containers designed to safely store and transport infectious, pathological, or otherwise hazardous waste generated by healthcare, laboratory, and pharmaceutical operations. Their relevance stems from stringent regulatory mandates and heightened public health awareness, especially post‑COVID‑19. The Biohazard Waste Bags market size reached approximately $3.2 billion in 2025, and industry analysts project a robust growth outlook with a CAGR of 6.5% through the 2026‑2033 market forecast, driven by expanding healthcare infrastructure, stricter waste‑management regulations, and a shift toward sustainable packaging. Key forces shaping the market include evolving regulatory frameworks (e.g., OSHA, EU Waste Framework Directive), the adoption of biodegradable polymer technologies, and intensified competitive dynamics as manufacturers innovate to meet cost‑efficiency and environmental criteria. North America remains the largest market by revenue, while the Asia‑Pacific region is emerging as the fastest‑growing segment due to rapid hospital construction and increasing awareness of biohazard safety.